Graphyne-based materials (GBMs), composed of mixed sp- and sp2-hybridized carbon networks, exhibit tunable pore architectures and unique electronic properties, enabling promising applications in energy, catalysis, and separation technologies.
This review summarizes recent advances in extracellular vesicle-based carriers for glioblastoma diagnosis and therapy, and points out the current challenges and perspectives.
This review explores the pathology of SCI and the characteristics of GBMs, focusing on recent in vitro and in vivo research on their mechanism, biocompatibility, toxicity, and biodegradability.
Techniques, characteristics, and uses of the graphene family have led to their emergence as a novel nanomaterial for cardiovascular applications.
Graphene-related materials are not skin corrosive and, if containing low surfactant residues, not skin irritant, as assessed on a 3D model of skin epidermis using the relevant OECD test guidelines.